Iolyx Therapeutics

Menlo Park, United States

Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.

$15.0M raised

Dec 2025

Series B

Biopharma Biotechnology Health Care

Top Investors

Alumni Ventures Frazier Healthcare Partners GC&H Investments

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Iolyx Therapeutics

How much funding has Iolyx Therapeutics raised?

Iolyx Therapeutics has raised $15.0M in total funding. The most recent round was Series B. The last funding was announced in December 2025.

Who are Iolyx Therapeutics's investors?

Iolyx Therapeutics's investors include Alumni Ventures, Frazier Healthcare Partners, GC&H Investments.

Where is Iolyx Therapeutics headquartered?

Iolyx Therapeutics is headquartered in Menlo Park, United States.

What does Iolyx Therapeutics do?

Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.

What stage is Iolyx Therapeutics at?

Iolyx Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 3, 2025.

MLA

"Iolyx Therapeutics — Funding & Investors." VCBacked, December 3, 2025, https://www.vcbacked.co/company/iolyx-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Iolyx Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/iolyx-therapeutics

Wikipedia (cite web)

{{cite web |title=Iolyx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/iolyx-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 3, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.